Back to Search
MAY WANG, MD
MD
Pediatrics Physician
NPI: 1972770162Individual
Specialties, Licenses & Credentials
Research & Publications (20)
CR represents an early index of potential long survival in multiple myeloma.
PMID 19633690·Bone Marrow Transplant·2010
8-other
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
PMID 19225534·Leukemia·2009
8-other
Intracellular delivery of proteins into mouse Müller glia cells in vitro and in vivo using Pep-1 transfection reagent.
PMID 19056421·J Neurosci Methods·2009
7-preclinical
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo.
PMID 17898787·Leukemia·2008
7-preclinical
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
PMID 18413598·Proc Natl Acad Sci U S A·2008
7-preclinical
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
PMID 18799726·Blood·2008
4-observational
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.
PMID 17558699·Hematology·2007
3-trial
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
PMID 17317853·Blood·2007
7-preclinical
Use of bortezomib in B-cell non-Hodgkin's lymphoma.
PMID 16831071·Expert Rev Anticancer Ther·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1600 PROVIDENCE DR
WACO, TX 76707 - Phone
- (254) 750-8200
Quick Facts
- NPI
- 1972770162
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile